{"id":"https://openalex.org/W2000997080","doi":"https://doi.org/10.1111/j.1365-2125.1989.tb03456.x","title":"Clinical pharmacology of vigabatrin.","display_name":"Clinical pharmacology of vigabatrin.","alternate_titles":[],"publication_year":1989,"publication_date":"1989-02-01","ids":{"openalex":"https://openalex.org/W2000997080","doi":"https://doi.org/10.1111/j.1365-2125.1989.tb03456.x","mag":"2000997080","pmid":"https://pubmed.ncbi.nlm.nih.gov/2667604","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1379674"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2125.1989.tb03456.x","doi":"https://doi.org/10.1111/j.1365-2125.1989.tb03456.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1989.tb03456.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1989.tb03456.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000997080"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1989.tb03456.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110246885","display_name":"PJ Schechter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"PJ Schechter","raw_affiliation_strings":["Merrell Dow Research Institute, Strasbourg, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merrell Dow Research Institute, Strasbourg, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5110246885"],"corresponding_institution_ids":[],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":3.4403,"has_fulltext":true,"cited_by_count":113,"citation_normalized_percentile":{"value":0.92111293,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"27","issue":"S1","first_page":"19S","last_page":"22S"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8705999851226807,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8705999851226807,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.10819999873638153,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vigabatrin","display_name":"vigabatrin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gaba-transaminase-inhibition","display_name":"GABA transaminase inhibition","score":0.8109999895095825},{"id":"https://openalex.org/keywords/gaba","display_name":"GABA","score":0.6600000262260437},{"id":"https://openalex.org/keywords/homocarnosine","display_name":"homocarnosine","score":0.9879999756813049},{"id":"https://openalex.org/keywords/beta-alanine","display_name":"beta-alanine","score":0.9610000252723694},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7310000061988831},{"id":"https://openalex.org/keywords/oral-absorption","display_name":"oral absorption","score":0.6299999952316284},{"id":"https://openalex.org/keywords/renal-excretion","display_name":"renal excretion","score":0.968999981880188},{"id":"https://openalex.org/keywords/cerebrospinal-fluid","display_name":"cerebrospinal fluid","score":0.8309999704360962},{"id":"https://openalex.org/keywords/dose-linearity","display_name":"dose linearity","score":0.7039999961853027},{"id":"https://openalex.org/keywords/neurological-disorders","display_name":"neurological disorders","score":0.859000027179718}],"concepts":[{"id":"https://openalex.org/C2780837902","wikidata":"https://www.wikidata.org/wiki/Q421663","display_name":"Vigabatrin","level":4,"score":0.9905992150306702},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7049757838249207},{"id":"https://openalex.org/C2777421860","wikidata":"https://www.wikidata.org/wiki/Q4637204","display_name":"GABA transaminase","level":4,"score":0.6333061456680298},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.5986272692680359},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5889232754707336},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5150660872459412},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.4721401035785675},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.46357136964797974},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33776819705963135},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.290219247341156},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.20237210392951965},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.18196174502372742},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1280328929424286},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C9497952","wikidata":"https://www.wikidata.org/wiki/Q419650","display_name":"Glutamate decarboxylase","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000612","descriptor_name":"4-Aminobutyrate Transaminase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000614","descriptor_name":"Aminocaproates","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D000614","descriptor_name":"Aminocaproates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000614","descriptor_name":"Aminocaproates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020888","descriptor_name":"Vigabatrin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2125.1989.tb03456.x","doi":"https://doi.org/10.1111/j.1365-2125.1989.tb03456.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1989.tb03456.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1989.tb03456.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:2667604","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2667604","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1379674","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1379674/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2125.1989.tb03456.x","doi":"https://doi.org/10.1111/j.1365-2125.1989.tb03456.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1989.tb03456.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1989.tb03456.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000997080.pdf","grobid_xml":"https://content.openalex.org/works/W2000997080.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1985174340","https://openalex.org/W1991459355","https://openalex.org/W1998186620","https://openalex.org/W2035352436","https://openalex.org/W2039225203","https://openalex.org/W2055924385","https://openalex.org/W2060417500","https://openalex.org/W2067402473","https://openalex.org/W2067740407","https://openalex.org/W2075780315","https://openalex.org/W2078162193","https://openalex.org/W2081758626","https://openalex.org/W2086729788","https://openalex.org/W2089921921","https://openalex.org/W2319178722","https://openalex.org/W2397974500"],"related_works":["https://openalex.org/W2011056884","https://openalex.org/W1990837904","https://openalex.org/W4244889425","https://openalex.org/W2001013519","https://openalex.org/W2126115260","https://openalex.org/W4299845981","https://openalex.org/W1524872820","https://openalex.org/W2049092870","https://openalex.org/W2164892541"],"abstract_inverted_index":{"1.":[0],"Upon":[1],"oral":[2,95],"administration":[3,96],"vigabatrin":[4,58,109],"is":[5,21],"rapidly":[6],"absorbed.":[7],"Plasma":[8],"elimination":[9],"half-life":[10],"ranges":[11],"between":[12],"5":[13],"and":[14,67,74,97],"7":[15],"h":[16],"in":[17,36,56,62,87,100,110,116],"normal":[18],"volunteers.":[19],"Vigabatrin":[20],"eliminated":[22],"primarily":[23],"via":[24],"the":[25,31,37,46,101,103],"kidneys":[26],"with":[27,81,91],"about":[28],"65%":[29],"of":[30,48,65,84,108],"administered":[32],"dose":[33],"found":[34],"unchanged":[35],"urine":[38],"within":[39,45],"24":[40],"h.":[41],"Kinetics":[42],"are":[43,79],"dose-linear":[44],"range":[47],"usual":[49],"therapeutic":[50,54],"doses.":[51],"2.":[52],"At":[53],"doses":[55],"man":[57],"produces":[59],"dose-related":[60],"increases":[61],"CSF":[63],"concentrations":[64],"free":[66],"total":[68],"GABA,":[69],"homocarnosine":[70],"(the":[71],"GABA-histidine":[72],"dipeptide)":[73],"beta-alanine.":[75],"These":[76],"biochemical":[77,98],"changes":[78],"consistent":[80],"an":[82],"inhibition":[83],"GABA-transaminase":[85],"activity":[86,99],"brain.":[88],"3.":[89],"Thus,":[90],"systemic":[92],"availability":[93],"upon":[94],"CNS,":[102],"prerequisites":[104],"for":[105],"potential":[106],"uses":[107],"neurological":[111],"disorders":[112],"have":[113],"been":[114],"demonstrated":[115],"clinical":[117],"pharmacological":[118],"studies.":[119]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000997080","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
